Your shopping cart is currently empty

Uridine adenosine tetraphosphate (UP4A) acts primarily as an endothelium-derived vasoconstrictor, exerting its effects mainly through the P2X1 receptor, and potentially through the P2Y2 and P2Y4 receptors as well. It is utilized in research related to cardiovascular diseases.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Uridine adenosine tetraphosphate (UP4A) acts primarily as an endothelium-derived vasoconstrictor, exerting its effects mainly through the P2X1 receptor, and potentially through the P2Y2 and P2Y4 receptors as well. It is utilized in research related to cardiovascular diseases. |
| Synonyms | UP4A |
| Molecular Weight | 813.35 |
| Formula | C19H27N7O21P4 |
| Cas No. | 10527-48-7 |
| Smiles | O[C@H]1[C@H](N2C=3C(N=C2)=C(N)N=CN3)O[C@H](COP(OP(OP(OP(OC[C@H]4O[C@H]([C@H](O)[C@@H]4O)N5C(=O)NC(=O)C=C5)(=O)O)(=O)O)(=O)O)(=O)O)[C@H]1O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.